Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio; Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.
J Allergy Clin Immunol Pract. 2020 Jul-Aug;8(7):2285-2293.e6. doi: 10.1016/j.jaip.2020.03.048. Epub 2020 Apr 14.
Nonlesional skin in atopic dermatitis (AD) is abnormal, but the pathobiology of lesional and nonlesional skin and the definition of endotypes are poorly understood.
To define lesional and nonlesional endotypes of AD by building the first US-based early-life prospective cohort of children with AD, the Mechanisms of Progression from AD to Asthma in Children cohort.
We assessed lesional and nonlesional skin transepidermal water loss, filaggrin (FLG) and alarmin (S100A8, S100A9) expression, staphylococcal colonization, and patterns of aeroallergen and food sensitization to define nonlesional and lesional phenotypes and endotypes.
Pathophysiologic changes were present in lesional and nonlesional skin and were associated with SCORing for Atopic Dermatitis. Nonlesional skin had features characteristic of diseased skin including low FLG and high alarmin expression, and increased colonization with Staphylococcus aureus. In a multivariate model, nonlesional, but not lesional, FLG expression was associated with the development of cosensitization and moderate to severe AD. Lesional skin was characterized by further deficits in FLG expression (P < .001), but alarmin expression was the same as observed in nonlesional skin.
This study reveals that events in the nonlesional, not the lesional, skin promote the subsequent development of AD severity and cosensitization, which is a key risk factor for allergic comorbidities. Collectively, these data suggest the presence of a subclinical eczema endotype that may predispose to the development of allergic disease in the absence of overt eczema. This may represent a new definition of the atopic march that starts with skin barrier dysfunction rather than eczema.
特应性皮炎(AD)的非皮损皮肤异常,但皮损和非皮损皮肤的发病机制以及表型定义仍知之甚少。
通过建立首个基于美国的特应性皮炎儿童前瞻性队列研究,即儿童 AD 向哮喘进展的机制研究,来定义 AD 的皮损和非皮损表型和表型。
我们评估了皮损和非皮损皮肤的经表皮水分丢失、丝聚蛋白(FLG)和警报素(S100A8、S100A9)的表达、葡萄球菌定植以及气传变应原和食物致敏的模式,以定义非皮损和皮损表型和表型。
皮损和非皮损皮肤均存在病理生理变化,与特应性皮炎评分相关。非皮损皮肤具有疾病皮肤的特征,包括低 FLG 和高警报素表达,以及金黄色葡萄球菌定植增加。在多变量模型中,非皮损而非皮损 FLG 表达与共致敏和中重度 AD 的发展相关。皮损皮肤的 FLG 表达进一步降低(P<0.001),但警报素表达与非皮损皮肤相同。
本研究表明,非皮损皮肤的事件而非皮损皮肤促进了 AD 严重程度和共致敏的后续发展,这是发生过敏合并症的关键危险因素。综上所述,这些数据表明存在亚临床湿疹表型,即使没有明显的湿疹也可能导致过敏疾病的发生。这可能代表了一种新的特应性发展定义,它起始于皮肤屏障功能障碍而非湿疹。